MERGERS & ACQUSITIONS

10 minute read

Jun. 24, 2024

Drug Hunter 2023 M&A Review: Part 2 – Small Molecule-Focused Deals Countdown

Author:

Oliver Philps

Reviewer:

Lew Pennington

Editor:

Other articles you may be interested in